Translational scientists and clinical pharmacology teams need to bridge a biomarker assay from a research-grade discovery format (e.g. research ELISA, MSD multiplex) to a fit-for-purpose clinical assay validated to bioanalytical guidelines, ensuring data continuity between Phase I and Phase II/III trials without compromising comparability.
All Clinical Biomarker Discovery & Validation agents · All Biotechnology & Life Sciences agents